Another novelty of this study is that the profound effect of “metabolic” multiple confounding factors (such as obesity, diabetes, hypertension, dyslipidemia, liver disease, chronic inflammation, and serum albumin level) was minimized through study design (exclusion of participants being treated for diabetes) and statistical correction. The gene discussed is ALB; the disease is obesity due to melanocortin 4 receptor deficiency.